RafaelAVegaMDPhD FAANS
Neurosurgery • Boston, MABrain & Spinal Tumor, Skull Base
Director of Neurosurgical and Skull Base Oncology at Beth Israel Deaconess Medical Center, Harvard Medical School
Dr. Vega is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
BIDMC/HMS - Neurosurgery
110 Francis St., Lowry Ste 3B
Boston, MA 02215Phone+1 617-632-7246Fax+1 617-632-0949- Is this information wrong?
Summary
- Dr. Rafael Vega is a board-certified neurosurgeon in Boston, MA and affiliated with Beth Israel Deaconess Medical Center, Harvard Medical School. He received his fellowship training at MD Anderson in Neurosurgical Oncology. He serves as Director of the Brain Tumor Center at BIDMC and is a Member of Dana-Farber/Harvard Cancer Center. He specializes in the treatment of malignant/benign brain tumors.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2018 - 2019
Virginia Commonwealth University Health SystemResidency, Neurological Surgery, 2011 - 2018
University of Virginia Medical CenterNeuro-Oncology Research, 2015 - 2016
University of Illinois College of MedicineClass of 2011, MD
Northwestern UniversityPhD, Chemistry of Life Processes, 2003 - 2007- University of ColoradoBS, Chemistry, with High Distinction, 2000 - 2003
Certifications & Licensure
MA State Medical License 2019 - 2025- American Board of Neurological Surgery Neurological Surgery
- The Society of Neurological SurgeonsCommittee on Advanced Subspecialty Training (CAST) in Neurosurgical Oncology
Awards, Honors, & Recognition
- Boston Magazine Top Doctor 2024
- Castle Connolly Top Doctor 2023-2024
- Fellow (FAANS) American Association of Neurological Surgeons, 2023
- Join now to see all
Clinical Trials
- Surgical Pembro +/- Olaparib w TMZ for rGBM Start of enrollment: 2022 Oct 21
Roles: Contact
- Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
- Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas Start of enrollment: 2022 Jun 20
Publications & Presentations
PubMed
- Synchronous contralateral low-grade oligodendroglioma and high-grade IDH-mutant astrocytoma.Bartholomew White, Jean Filo, Eduardo Orrego-Gonzalez, Steven N Schwartz, Hemant Varma, Erik J Uhlmann, Rafael A Vega> ;Journal of Neuropathology and Experimental Neurology. 2023 Nov 20
- Double cranial stair-step incision: A method for prophylactic closure of high-risk neurosurgical procedures.Shannon R Garvey, Aristotelis S Filippidis, Amy Chen, Macie L Gettings, Rafael A Vega, Ryan P Cauley> ;Journal of Plastic, Reconstructive & Aesthetic Surgery. 2023 Dec 1
- Surgery in octogenarians with intracranial meningiomas improves functional outcome at 1 year.Aristotelis S Filippidis, Katharine R Phillips, Victor Lopez-Rivera, Alejandro Enriquez-Marulanda, Charles E Mackel, Ron L Alterman, Rafael A Vega> ;Acta Neurochirurgica. 2023 Dec 1
- Join now to see all
Books/Book Chapters
Committees
- Co-Chair, CNS Journal Club Podcast 2019 - Present
Professional Memberships
- Member
- Member
- Member
- Society of Neuro-OncologyMember
- North American Skull Base SocietyMember
Other Languages
- Spanish
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
External Links
- DF/HCC Profilehttps://www.dfhcc.harvard.edu/insider/member-detail/member/rafael-a-vega-md-phd/
- BIDMC Brain Tumor Centerhttps://www.bidmc.org/centers-and-departments/cancer-center/cancer-center-programs-and-services/brain-tumor-program
- BIDMC Neurosurgeryhttps://www.bidmc.org/centers-and-departments/neurosurgery
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
